chang pan liu - Infectious Diseases

Author Information

Chang-Pan Liu is a renowned expert in the field of Infectious Diseases, serving in multiple capacities at the MacKay Memorial Hospital in Taipei, Taiwan. He is affiliated with the Division of Infectious Diseases in the Department of Internal Medicine and the Section of Microbiology in the Department of Medical Research at the hospital. Additionally, he is associated with the MacKay Medical College in Taipei. His work primarily focuses on infectious diseases and microbiology, contributing significantly to both clinical and molecular research.

Research Contributions

Dr. Chang-Pan Liu has made substantial contributions to the study of infectious diseases, particularly in understanding antimicrobial resistance and the clinical outcomes of various bacterial infections. His research has covered a wide range of topics including the prognosis of COVID-19 patients, the characteristics of carbapenem-resistant Enterobacterales, and the surveillance of antimicrobial resistance in Streptococcus pneumoniae. He has also explored the efficacy of new antimicrobial agents against resistant strains of bacteria like Enterococcus faecium and Pseudomonas aeruginosa. His studies are pivotal in informing treatment strategies and improving clinical outcomes in the management of infectious diseases.

Aliases

Throughout his academic and research career, Chang-Pan Liu has been referred to by various aliases including Chang-pan Liu and Changxin Liu. These variations are commonly found in academic publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	1555
H-index	23
Paper Count	91

Publications:

Characteristics and Prognosis of Antibody Non-Responders with COVID-19

DOI: 10.21203/rs.3.rs-1015563/v1

Year: 2021

Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.

DOI: 10.1016/j.jmii.2021.10.008

Year: 2021

Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019.

DOI: 10.1016/j.jmii.2021.05.008

Year: 2021

National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Res

DOI: 10.1016/j.jgar.2021.07.005

Year: 2021

An Actinobacterial Isolate, Streptomyces sp. YX44, Produces Broad-Spectrum Antibiotics That Strongly Inhibit Staphylococcus aureus

DOI: 10.3390/microorganisms9030630

Year: 2021

In vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline, and other comparative agents against carbapenem-nonsusceptible Enterobacterales: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020.

DOI: 10.1016/j.ijantimicag.2021.106377

Year: 2021

Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019/2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).

DOI: 10.1016/j.ijantimicag.2021.106353

Year: 2021

The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment.

DOI: 10.1016/j.jmii.2021.03.013

Year: 2021

In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020.

DOI: 10.1016/j.jmii.2021.08.012

Year: 2021

Clinical and molecular characterization of Acinetobacter seifertii in Taiwan.

DOI: 10.1093/jac/dkaa432

Year: 2020

How is Pink Eye Diagnosed?

How do Bacteria Cause Diseases?

What role does global travel play in the spread of infectious diseases?

How Can Adverse Effects be Minimized?

What Diseases are Transmitted by Culex Mosquitoes?

How Can Herpes Be Prevented?

What is the Global Impact of Malaria?

What Role Does Vaccination Play in Global Health?

What is Epigenetics?

What is Public Health?

Partnered Content Networks

Relevant Topics